(R)-(+)-Trityl glycidyl ether

(R)-(+)-Trityl glycidyl ether

• CAS Number: 65291-30-7
• UNSPSC Description: (R)-(+)-Trityl glycidyl ether, a heterocyclic compound, is a precursor that can be used to synthesize glycerophospholipids, as well as compounds with antiviral and antimalarial activities[1][2].
• Target Antigen: Drug Intermediate
• Type: Reference compound
• Related Pathways: Others
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/r-plus-trityl-glycidyl-ether.html
• Purity: 97.0
• Smiles: [C@@H]1(CO1)COC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4
• Molecular Weight: 316.39
• References & Citations: [1]Baszczyňski O, et al. Synthesis and antiviral activity of N9-[3-fluoro-2-(phosphonomethoxy)propyl] analogues derived from N6-substituted adenines and 2,6-diaminopurines. Bioorg Med Chem. 2011 Apr 1;19(7):2114-24. |[2]Sato E, et al. Design, synthesis and anti-malarial activities of synthetic analogs of biselyngbyolide B, a Ca2+ pump inhibitor from marine cyanobacteria. Bioorg Med Chem Lett. 2018 Feb 1;28(3):298-301.
• Shipping Conditions: Room Temperature
• Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
• Clinical Information: No Development Reported